ArticleScientific reports2025
Association of grass pollen concentration and physical symptoms as well as impairments in day-to-day life in pollen allergy patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prospective Evaluation of Symptom Burden and Medication Use in Seasonal Allergic Rhinitis/Rhinoconjunctivitis Patients Considering Allergen-Specific Immunotherapy.Journal of clinical medicine · 2026Article
- Molecular Biomarkers in IgE Immunoassays Used for Grass Pollen Allergy Diagnosis in European Clinical Settings.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic diseases are a major global public health issue, profoundly impacting the daily lives of millions of people worldwide. The aim of this study is to investigate the association between daily grass pollen concentration and daily physical symptoms as well as impairments in day-to-day life in pollen allergy patients in Bavaria, Germany over a period of three-months. Pollen data of the pollen season 2022 were obtained from the electronic pollen information network of Bavaria. We used an app-based questionnaire and developed an index to measure physical symptoms-regarding eyes and nose as well as impairments in day-to-day life including performance, sleep quality and daily activities. For our analyses we used data from 53 patients. The associations were analysed using linear mixed models (LMM). We found a statistically significant association between the level of grass pollen concentration and both the index physical symptoms (β = 0.002; p < 0.001) and the index impairments in day-to-day life (β = 0.00064; p < 0.048). It is important that patients are well informed about the pollen count as well as their physical symptoms and daily life impairments so that they can manage their allergies effectively and appropriately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.